Cargando…
Fusobacterium nucleatum: a novel immune modulator in breast cancer?
Breast cancer was the most commonly diagnosed cancer worldwide in 2020. Greater understanding of the factors which promote tumour progression, metastatic development and therapeutic resistance is needed. In recent years, a distinct microbiome has been detected in the breast, a site previously though...
Autores principales: | Little, Alexa, Tangney, Mark, Tunney, Michael M., Buckley, Niamh E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407221/ https://www.ncbi.nlm.nih.gov/pubmed/37009688 http://dx.doi.org/10.1017/erm.2023.9 |
Ejemplares similares
-
Fusobacterium nucleatum and cancer
por: Alon‐Maimon, Tamar, et al.
Publicado: (2022) -
Fusobacterium nucleatum and Colorectal Cancer
por: Li, Rongrong, et al.
Publicado: (2022) -
Fusobacterium nucleatum-positive colorectal cancer
por: Yang, Zhenhua, et al.
Publicado: (2019) -
Fusobacterium nucleatum and colorectal cancer: A review
por: Shang, Fu-Mei, et al.
Publicado: (2018) -
Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum
por: Brennan, Caitlin A., et al.
Publicado: (2021)